API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

Paliperidone palmitate: pharmacokinetics, clinical applications and safety

Paliperidone palmitate is an effective treatment for schizophrenia. It has a stable half-life, lower risk of side effects, and improved medication adherence.

Sep 28,2023  API

Dodecanedioic acid: pharmacokinetics and applications

Dodecanedioic acid is a versatile dicarboxylic acid used in polyamides, providing exceptional properties for various industrial applications.

Sep 28,2023  API

2-Phenylimidazole: applications in wastewater treatment and safety

2-Phenylimidazole is used in wastewater treatment, specifically for petrochemical wastewater and phosphorus removal.

Sep 28,2023  API

2-Chlorotoluene: properties, applications and safety

2-Chlorotoluene is a hazardous, flammable liquid used as a solvent and intermediate in organic chemistry.

Sep 28,2023  API

Amitraz: mechanism of action and toxicity

Amitraz poisons pests by disrupting their nervous system, causing paralysis, feeding inhibition, and reproductive impairment.

Sep 28,2023  API

The side effects of GW-501516

GW-501516 is a peroxisome proliferator-activated receptor (PPAR) agonists. It may cause several side effects.

Sep 27,2023  API

Astragaloside IV: mechanism of action, pharmacokinetics and toxicity

Astragaloside IV in radix astragalus protects against heart failure by improving cardiac function and regulating calcium balance. It has limited absorption and low toxicity.

Sep 27,2023  API

Esomeprazole magnesium: mechanism of action, pharmacokinetics and safety

Esomeprazole magnesium reduces stomach acid production by selectively inhibiting the proton pump, providing long-lasting relief from excessive acid symptoms.

Sep 27,2023  API

Olmesartan medoxomil: pharmacological properties, therapeutic efficacy and tolerability

Olmesartan medoxomil is an effective and safe ARB that lowers blood pressure, improves arterial compliance, and protects against end-organ damage.

Sep 27,2023  API

Antioxidant 1330: properties, applications in the field of materials and safety

Antioxidant 1330 is a stable and heat-resistant white crystalline powder used to enhance material resistance to degradation caused by heat and oxidative stress, with low toxicity.

Sep 27,2023  API
Prev12345678910...Next>  Go to Page